DA-8010

· Dong-A ST Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for DA-8010, covering 2016-07-01 to 2024-06-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive Bladder [Phase 3]